chemotherapy

(redirected from induction chemotherapy)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to induction chemotherapy: maintenance chemotherapy, consolidation chemotherapy

che·mo·ther·a·py

 (kē′mō-thĕr′ə-pē, kĕm′ō-)
n.
1. The treatment of cancer using specific chemical agents or drugs that are selectively destructive to malignant cells and tissues.
2. The treatment of disease using chemical agents or drugs that are selectively toxic to the causative agent of the disease, such as a virus, bacterium, or other microorganism.

che′mo·ther′a·peu′tic (-pyo͞o′tĭk) adj.
che′mo·ther′a·peu′ti·cal·ly adv.
che′mo·ther′a·pist n.

chemotherapy

(ˌkiːməʊˈθɛrəpɪ; kiːmə-)
n
(Medicine) treatment of disease, esp cancer, by means of chemical agents. Compare radiotherapy
ˌchemoˈtherapist n

che•mo•ther•a•py

(ˌki moʊˈθɛr ə pi, ˌkɛm oʊ-)

n.
the treatment of disease by means of chemicals that have a specific toxic effect upon the disease-producing microorganisms or that selectively destroy cancerous tissue.
[1905–10]
che`mo•ther`a•peu′tic (-ˈpyu tɪk) adj.
che`mo•ther′a•pist, n.

che·mo·ther·a·py

(kē′mō-thĕr′ə-pē)
The treatment of disease, especially cancer, with chemicals that have a specific poisonous effect on the cancerous or disease-causing cells.

chemotherapy

Med. the treatment of disease by the use of chemicals that have a toxic effect on the microorganisms causing the disease or that selectively destroy tumor tissues. — chemotherapist, n. — chemotherapeutic, adj.
See also: Remedies
a procedure that uses radioisotopes of various elements, as iodine, phosphorus, and gold, to treat cancers of the thyroid gland, lungs, and other organs.
See also: Cancer

chemotherapy

Treatment of disease, especially cancer, and infection using drugs or chemical agents.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.chemotherapy - the use of chemical agents to treat or control disease (or mental illness)
therapy - (medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"
chrysotherapy - the use of chemicals containing gold for treating diseases (such as rheumatoid arthritis)
Translations
chemoterapie
kemoterapia
kemoterápia

chemotherapy

[ˈkiːməʊˈθerəpɪ] Nquimioterapia f

chemotherapy

[ˌkiːməʊˈθɛrəpi] nchimiothérapie f

chemotherapy

chemotherapy

[ˌkiːməʊˈθɛrəpɪ] n (Med) → chemioterapia

che·mo·ther·a·py

n. quimioterapia, tratamiento de una enfermedad por medio de agentes químicos.

chemotherapy

n (pl -pies) quimioterapia; adjuvant — quimioterapia adyuvante; consolidation — quimioterapia de consolidación; high-dose — quimioterapia a dosis altas; induction — quimioterapia de inducción; neoadjuvant — quimioterapia neoadyuvante
References in periodicals archive ?
The compound is currently under development in a multi-national phase III trial in combination with Azacitidine for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are unfit for intensive induction chemotherapy; Pracinostat is also being tested in an open label phase II study in combination with Azacitidine for the treatment of naive patients with high risk myelodysplastic syndromes (MDS).
Pracinostat is an oral HDAC that is in a pivotal Phase III study in combination with Azacitidine for the treatment of adults with newly diagnosed acute myeloid leukemia ("AML") who are unfit for intensive induction chemotherapy. It is also being evaluated in a Phase II study in patients with high risk myelodysplastic syndromes ("MDS").
The baseline means serum SCr and eGFR was 0.46+-0.166 mg/dl and143.66+-58ml/min/1.73 m2respectively.Table-II Comparative changes in various biochemical parameters from base line (D0) to D3 and D7 of induction chemotherapy are shown in Table-III.
Myelosuppressive or Induction chemotherapy is anticipated to grow significantly due to growing pool of cancer patients.
Regimen-A included three drugs (dexamethasone, vincristine and asparaginase) and Regimen-B included four drugs (dexa-methasone, vincristine, asparaginase and daunorubicin) Remission status was assessed after 1 month of induction chemotherapy by blood complete counts and bone marrow examination.
The product (ivosidenib) is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated in the United States as a treatment for acute myeloid leukaemia with a susceptible IDH1 mutation under the conditions where in patients with newly diagnosed IDH1-susceptible acute myeloid leukaemia who are up to 75 years old or have comorbidities that preclude the use of intensive induction chemotherapy and in adult patients with R/R AML with a susceptible IDH1 mutation as detected by an FDA-approved test.
As of the data cutoff of May 10, 46 patients had been treated in the Phase 1b portion of the trial, including 10 r/r MDS or AML patients who received monotherapy 5F9, and 36 untreated higher-risk MDS patients or untreated AML patients ineligible for induction chemotherapy, who received 5F9 in combination with azacitidine.
At the end of induction chemotherapy, his clinical status improved substantially.
Food and Drug Administration (FDA) approved DAURISMO (glasdegib), a once-daily oral medicine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are 75 years or older or who have comorbidities that preclude use of intensive induction chemotherapy. DAURISMO is taken in combination with low-dose cytarabine (LDAC), a type of chemotherapy.
Biopharmaceutical company AbbVie (NYSE:ABBV) revealed on Wednesday the receipt of the US Food and Drug Administration's (FDA) accelerated approval for VENCLEXTA (venetoclax tablets) in combination with azacitidine, or decitabine, or low-dose cytarabine (LDAC) for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are age 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
At this stage, due to the patient's poor condition of respiratory distress and severe thrombocytopenia, it was not possible to perform cardiac lesions' biopsy and the patient was treated with induction chemotherapy by mitoxantrone and cytosor.
On day 31 of induction chemotherapy, she was noticed to have enlarged right cervical lymph nodes (level 3 and 4).